Revenue cycle · Specialty patient payments
Rivia Health
Rivia Health provides patient-payment and billing-engagement software for specialty and ambulatory practices, including estimates, reminders, payment plans, and collections workflows. It is not a claim-editing or autonomous coding engine.
Strong fit
- Specialty and ambulatory practices that need patient estimates, payment plans, and billing communications without an enterprise patient-pay suite
- Teams that will measure patient-pay yield and aging A/R after cutover
- Buyers comparing early mid-market patient-pay tools rather than Cedar-scale platforms
Weak fit
- Health systems standardizing on enterprise patient financial engagement
- Buyers who only need claim editing
- Organizations unwilling to change statement and collections workflows
Bottom line
Rivia Health earns a Conditional for specialty practices that want modern patient-payment and estimate workflows from a smaller vendor. The product thesis matches Collectly and PatientPay on patient billing; commercial scale and published pricing clarity are thinner, which keeps the label Conditional. Outcomes depend on specialty billing ops adoption. Implementation is practice billing change management. Pricing is custom (SaaS plus transaction economics in some packages). Third-party revenue estimates sit near $3M. Score sits under PatientPay on our revenue-cycle patient-pay cluster.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Rivia Health builds patient-payment and revenue-cycle engagement software for specialty and ambulatory practices, including estimates, reminders, payment plans, and collections workflows.
Compare PatientPay and Collectly for broader patient billing automation, and Phreesia when intake and payments ship together.
Conditional reflects early mid-market scale on our revenue-cycle board.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Rivia Health | 6.5 | 6.4 |
| PatientPay | 7.0 | 7.0 |
| Collectly | 7.4 | 7.2 |
| Aptarro | 7.0 | 6.8 |
| MDaudit | 7.4 | 7.1 |
| MD Clarity | 6.9 | 6.7 |
| Phreesia | 8.2 | 7.8 |
| Nym | 6.6 | 6.4 |
Pricing
| Item | Detail |
|---|---|
| Model | Custom SaaS for patient estimates, billing communications, and payments; some packages include transaction fees. |
| What usually drives cost | Practice size, payment volume, specialty modules, and messaging volume. |
| What to ask in diligence | Monthly SaaS plus payment fees at your volume, and onboarding scope. |
| Published pricing | Public list price: not published. Expect a specialty practice patient-pay quote. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Rivia Health to function | |
| RCM owner with authority to change edit and billing workflows | Software without owners becomes shelfware. |
| Baseline clean-claim, denial, or patient-pay metrics captured | You cannot prove value without a before number. |
| PM/EHR interface path and test claims ready | Orphan edits create more rework. |
| Staffing plan for work queues after go-live | Unowned queues age into write-offs. |
| Payer mix and top denial or statement reasons documented | Generic rules miss your real leaks. |
| What will maximize your value | |
| Track clean-claim rate or patient-pay yield weekly for 90 days | Feature tours are not outcomes. |
| Tune the top denial or statement reasons in month one | Boiling the ocean delays cash. |
| Turn off redundant manual workarounds after parallel week | Dual paths erase the gain. |
| Review aged work-queue items in a standing huddle | Silent aging hides failure. |
| Publish a monthly cash and denial digest to finance leaders | Hidden leakage surprises the CFO. |
| Deal-breakers | |
| Nobody will own edit or billing queues. | |
| You refuse PM/EHR interface work the product needs. | |
| You expect an EHR replacement from an RCM tool. | |
| Leadership will not measure cash or denial outcomes. | |
| Compliance blocks the patient-communication path you require. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Scope & baseline | 2–4 weeks — Metrics, interfaces, rule/statement scope. |
| 2 | Configure | 4–10 weeks — Rules, templates, PM hooks; test claims. |
| 3 | Pilot | 2–6 weeks — One entity or payer family. |
| 4 | Optimize | Ongoing — Rule tuning; queue burn-down. |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.